TTOO T2 Biosystems Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TTOO

Price (delayed)

$2.98

Market cap

$16.43M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$19.19

Enterprise value

$49.68M

T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster ...

Highlights
The EPS has soared by 98% YoY and by 88% from the previous quarter
TTOO's net income is up by 19% year-on-year
TTOO's equity is down by 46% since the previous quarter but it is up by 29% year-on-year
T2 Biosystems's gross margin has shrunk by 130% QoQ
T2 Biosystems's quick ratio has shrunk by 78% YoY and by 34% QoQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.t2biosystems.com
Peers: ALDX ALIM CDNA GERN

Key stats

What are the main financial stats of TTOO
Market
Shares outstanding
5.51M
Market cap
$16.43M
Enterprise value
$49.68M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.08
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.91
Earnings
Revenue
$7.19M
EBIT
-$44.73M
EBITDA
-$42.53M
Free cash flow
-$48.33M
Per share
EPS
-$19.19
Free cash flow per share
-$18.52
Book value per share
-$6.92
Revenue per share
$2.76
TBVPS
$13.33
Balance sheet
Total assets
$34.8M
Total liabilities
$62.83M
Debt
$49.5M
Equity
-$28.04M
Working capital
-$30.96M
Liquidity
Debt to equity
-1.77
Current ratio
0.45
Quick ratio
0.31
Net debt/EBITDA
-0.78
Margins
EBITDA margin
-591.3%
Gross margin
-113.6%
Net margin
-696.2%
Operating margin
-690.4%
Efficiency
Return on assets
-135.4%
Return on equity
N/A
Return on invested capital
-175.7%
Return on capital employed
N/A
Return on sales
-621.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TTOO stock price

How has the T2 Biosystems stock price performed over time
Intraday
-0.33%
1 week
-5.1%
1 month
-14.61%
1 year
-92%
YTD
-52.51%
QTD
-0.67%

Financial performance

How have T2 Biosystems's revenue and profit performed over time
Revenue
$7.19M
Gross profit
-$8.17M
Operating income
-$49.66M
Net income
-$50.08M
Gross margin
-113.6%
Net margin
-696.2%
TTOO's operating margin has dropped by 179% year-on-year and by 52% since the previous quarter
The net margin has plunged by 150% YoY and by 54% from the previous quarter
T2 Biosystems's gross margin has shrunk by 130% QoQ
The revenue has plunged by 68% YoY and by 35% from the previous quarter

Growth

What is T2 Biosystems's growth rate over time

Valuation

What is T2 Biosystems stock price valuation
P/E
N/A
P/B
N/A
P/S
1.08
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.91
The EPS has soared by 98% YoY and by 88% from the previous quarter
TTOO's equity is down by 46% since the previous quarter but it is up by 29% year-on-year
The P/S is 83% below the 5-year quarterly average of 6.3 and 64% below the last 4 quarters average of 3.0
The revenue has plunged by 68% YoY and by 35% from the previous quarter

Efficiency

How efficient is T2 Biosystems business performance
The ROS has plunged by 148% YoY and by 55% from the previous quarter
The ROIC has plunged by 131% YoY and by 61% from the previous quarter
The ROA has grown by 9% YoY

Dividends

What is TTOO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TTOO.

Financial health

How did T2 Biosystems financials performed over time
TTOO's total assets is 45% less than its total liabilities
T2 Biosystems's quick ratio has shrunk by 78% YoY and by 34% QoQ
The current ratio has plunged by 76% YoY and by 24% from the previous quarter
TTOO's equity is down by 46% since the previous quarter but it is up by 29% year-on-year
The debt to equity has grown by 31% from the previous quarter but it has contracted by 19% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.